Federal award
VENATORX PHARMACEUTICALS INC
HDTRA117C0070
Contract
Obligated and Ceiling
- Obligated (net)
- $14,256,515.14
- Ceiling (potential value, not spending)
- $19,969,099.47
- Current value
- $14,716,732.53
- Gross positive obligations
- $14,716,732.53
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- VENATORX PHARMACEUTICALS INC · MBBKNBU5DCC6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- VENATORX PHARMACEUTICALS INC · MBBKNBU5DCC6
- Awarding agency
- Department of War · sub-agency 9761 · office HDTRA1
- Funding agency
- Department of War · sub-agency 9761
- Product or service (PSC)
- AD92 · R&D- DEFENSE OTHER: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- HDTRA117C0070
- Award type code
- D
- Actions
- 14 · Aug 18, 2017 to Apr 30, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History14
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 30, 2026 | FY2026 | P00013 | M | $0.00 | — |
| Feb 17, 2026 | FY2026 | P00012 | C | −$460,217.39 | — |
| Apr 22, 2021 | FY2021 | P00011 | C | $1,915,975.23 | — |
| Apr 15, 2021 | FY2021 | P00010 | B | $1,048,217.50 | — |
| Dec 10, 2020 | FY2021 | P00009 | B | $0.00 | — |
| Sep 23, 2020 | FY2020 | P00008 | B | $1,040,729.82 | — |
| Jun 24, 2020 | FY2020 | P00007 | B | $0.00 | — |
| Feb 24, 2020 | FY2020 | P00006 | C | $1,856,629.94 | — |
| Dec 13, 2019 | FY2020 | P00005 | C | $1,281,875.00 | — |
| May 6, 2019 | FY2019 | P00004 | G | $2,500,000.00 | — |
| Jan 30, 2019 | FY2019 | P00003 | B | $1,373,305.04 | — |
| May 22, 2018 | FY2018 | P00002 | C | $2,600,000.00 | — |
| Mar 8, 2018 | FY2018 | P00001 | C | $400,000.00 | — |
| Aug 18, 2017 | FY2017 | 0 | — | $700,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.